Bacterial meningitis
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
immunocompetent
empiric antibiotic therapy
Until the causative organism and its sensitivities have been identified, broad-spectrum antimicrobials should be given parenterally.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com [68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com
The choice of empiric antibiotic depends on the patient's age and conditions that may have predisposed the patient to meningitis.[65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
The regimen chosen must be broad enough to cover the potential organisms for the age group affected.
For initial therapy, likely antimicrobial resistance should be assumed.[65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
If a cephalosporin cannot be administered (e.g., with an allergy), an alternative antibiotic for neonates is an aminoglycoside (e.g., gentamicin).[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Primary options
ampicillin: consult specialist for guidance on dose
and
cefotaxime: consult specialist for guidance on dose
Secondary options
ampicillin: consult specialist for guidance on dose
and
gentamicin: consult specialist for guidance on dose
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
empiric antibiotic therapy
Until the causative organism and its sensitivities have been identified, broad-spectrum antimicrobials should be given parenterally.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com [68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com
The regimen chosen must be broad enough to cover the potential organisms for the age group affected.
For initial therapy, likely antimicrobial resistance should be assumed.[65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
If a cephalosporin cannot be administered (e.g., with an allergy), alternative antibiotics are a carbapenem (e.g., meropenem) or chloramphenicol.
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Primary options
vancomycin: children: 15 mg/kg intravenously every 6 hours; adults: 15-20 mg/kg intravenously every 8-12 hours
-- AND --
ceftriaxone: children: 100 mg/kg/day intravenously given in divided doses every 12-24 hours; adults: 2 g intravenously every 12 hours
or
cefotaxime: children: 200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
vancomycin: children: 15 mg/kg intravenously every 6 hours; adults: 15-20 mg/kg intravenously every 8-12 hours
-- AND --
meropenem: children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
or
chloramphenicol: children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
dexamethasone
Treatment recommended for ALL patients in selected patient group
Ideally, adjuvant dexamethasone should be given with or shortly before the first dose of parenteral antibiotics in all previously well and non-immunosuppressed adults and children.[68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com However, it may be given within 4 hours of the first dose of antibiotics.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Evidence of potential benefit has been demonstrated in cases of bacterial meningitis associated with Haemophilus influenzae or Streptococcus pneumoniae. There is little evidence to support the use of dexamethasone in cases caused by other bacteria (e.g., in cases of meningococcal meningitis); dexamethasone should be stopped early when H influenzae and S pneumoniae have been excluded as causative organisms.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Adjunctive therapy with dexamethasone, given before or within 4 hours of the first dose of antibiotics and continued for 4 days, has been shown to improve outcomes in adults.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com [71]de Gans J, van der Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56. https://www.nejm.org/doi/10.1056/NEJMoa021334 http://www.ncbi.nlm.nih.gov/pubmed/12432041?tool=bestpractice.com [72]van de Beek D, de Gans J, McIntyre P, et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43. http://www.ncbi.nlm.nih.gov/pubmed/14998499?tool=bestpractice.com [73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com [74]Beez T, Steiger HJ, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis. BMC Neurol. 2017 Dec 7;17(1):209. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-017-0994-z http://www.ncbi.nlm.nih.gov/pubmed/29212462?tool=bestpractice.com
One Cochrane review found insufficient evidence to demonstrate that adding corticosteroids to antibacterial therapy reduced overall mortality in a mixed population of adults and children with acute bacterial meningitis.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
Significant reduction in rates of hearing loss and neurologic sequelae were, however, reported in adults and children; short-term neurologic sequelae were reduced in children, but not in adults.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
[ ]
In children with acute bacterial meningitis, is there randomized controlled trial evidence to support adding corticosteroids to standard treatment with antibacterial agents?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1217/fullShow me the answer
[
]
In adults with acute bacterial meningitis, is adding corticosteroids to standard treatment with antibacterial agents helpful?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1273/fullShow me the answer These results were replicated in a subsequent meta-analysis of randomized controlled trials related to the treatment of bacterial meningitis in children with dexamethasone.[75]Wang Y, Liu X, Wang Y, et al. Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children. Childs Nerv Syst. 2018 Feb;34(2):217-23.
http://www.ncbi.nlm.nih.gov/pubmed/29188363?tool=bestpractice.com
Subgroup analyses of the Cochrane review suggested that corticosteroids may reduce: mortality in S pneumoniae meningitis (but not in H influenzae type b [Hib] or Neisseria meningitidis meningitis); severe hearing loss in children with Hib meningitis (but not in children with meningitis due to non-Haemophilus species).[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
One meta-analysis that included a heterogeneous group of critically ill adult patients reported potentially improved survival among a subgroup of patients with bacterial meningitis who received corticosteroids compared with those who did not (mortality 28% vs. 32%; P=0.04).[76]Martino EA, Baiardo Redaelli M, Sardo S, et al. Steroids and survival in critically ill adult patients: a meta-analysis of 135 randomized trials. J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2252-60. http://www.ncbi.nlm.nih.gov/pubmed/29793761?tool=bestpractice.com
Primary options
dexamethasone sodium phosphate: children ≥1 month of age: 0.6 mg/kg/day intravenously given in divided doses every 6 hours; adults: 10 mg intravenously every 6 hours
empiric antibiotic therapy
Until the causative organism and antibiotic sensitivities have been identified, broad-spectrum antimicrobials should be given parenterally.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com [68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com
Choice of empiric antibiotic depends on patient's age and conditions that may have predisposed the patient to meningitis.[65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
The regimen chosen must be broad enough to cover the potential organisms for the age group affected.
For initial therapy, likely antimicrobial resistance should be assumed.[65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
If a cephalosporin cannot be administered (e.g., with an allergy), alternative antibiotics are a carbapenem (e.g., meropenem) or chloramphenicol. Trimethoprim/sulfamethoxazole is an alternative drug for ampicillin.
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Primary options
ampicillin: 2 g intravenously every 4 hours
and
vancomycin: 15-20 mg/kg intravenously every 8-12 hours
-- AND --
ceftriaxone: 2 g intravenously every 12 hours
or
cefotaxime: 2 g intravenously every 4 hours
Secondary options
sulfamethoxazole/trimethoprim: 8-10 mg/kg/day intravenously given in divided doses every 6-12 hours
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
and
vancomycin: 15-20 mg/kg intravenously every 8-12 hours
-- AND --
meropenem: 1-2 g intravenously every 8 hours
or
chloramphenicol: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
dexamethasone
Treatment recommended for ALL patients in selected patient group
Ideally, adjuvant dexamethasone should be given with or shortly before the first dose of parenteral antibiotics in all previously well and non-immunosuppressed adults and children.[68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com However, it may be given within 4 hours of the first dose of antibiotics.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Evidence of potential benefit has been demonstrated in cases of bacterial meningitis associated with Haemophilus influenzae or Streptococcus pneumoniae. There is little evidence to support the use of dexamethasone in cases caused by other bacteria (e.g., in cases of meningococcal meningitis); dexamethasone should be stopped early when H influenzae and S pneumoniae have been excluded as causative organisms.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Adjunctive therapy with dexamethasone, given before or within 4 hours of the first dose of antibiotics and continued for 4 days, has been shown to improve outcomes in adults.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com [71]de Gans J, van der Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56. https://www.nejm.org/doi/10.1056/NEJMoa021334 http://www.ncbi.nlm.nih.gov/pubmed/12432041?tool=bestpractice.com [72]van de Beek D, de Gans J, McIntyre P, et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43. http://www.ncbi.nlm.nih.gov/pubmed/14998499?tool=bestpractice.com [73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com [74]Beez T, Steiger HJ, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis. BMC Neurol. 2017 Dec 7;17(1):209. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-017-0994-z http://www.ncbi.nlm.nih.gov/pubmed/29212462?tool=bestpractice.com
One Cochrane review found insufficient evidence to demonstrate that adding corticosteroids to antibacterial therapy reduced overall mortality in a mixed population of adults and children with acute bacterial meningitis.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
Significant reduction in rates of hearing loss and neurologic sequelae were, however, reported in adults and children; short-term neurologic sequelae were reduced in children, but not in adults.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
[ ]
In children with acute bacterial meningitis, is there randomized controlled trial evidence to support adding corticosteroids to standard treatment with antibacterial agents?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1217/fullShow me the answer
[
]
In adults with acute bacterial meningitis, is adding corticosteroids to standard treatment with antibacterial agents helpful?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1273/fullShow me the answer These results were replicated in a subsequent meta-analysis of randomized controlled trials related to the treatment of bacterial meningitis in children with dexamethasone.[75]Wang Y, Liu X, Wang Y, et al. Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children. Childs Nerv Syst. 2018 Feb;34(2):217-23.
http://www.ncbi.nlm.nih.gov/pubmed/29188363?tool=bestpractice.com
Subgroup analyses of the Cochrane review suggested that corticosteroids may reduce: mortality in S pneumoniae meningitis (but not in H influenzae type b [Hib] or Neisseria meningitidis meningitis); severe hearing loss in children with Hib meningitis (but not in children with meningitis due to non-Haemophilus species).[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
One meta-analysis that included a heterogeneous group of critically ill adult patients reported potentially improved survival among a subgroup of patients with bacterial meningitis who received corticosteroids compared with those who did not (mortality 28% vs. 32%; P=0.04).[76]Martino EA, Baiardo Redaelli M, Sardo S, et al. Steroids and survival in critically ill adult patients: a meta-analysis of 135 randomized trials. J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2252-60. http://www.ncbi.nlm.nih.gov/pubmed/29793761?tool=bestpractice.com
Primary options
dexamethasone sodium phosphate: 10 mg intravenously every 6 hours
immunocompromised
empiric antibiotic therapy
Until the causative organism and antibiotic sensitivities have been identified, broad-spectrum antimicrobials should be given parenterally.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com [68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com
Choice of empiric antibiotic depends on patient's age and conditions that may have predisposed the patient to meningitis.[65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
The regimen chosen must be broad enough to cover the potential organisms for the age group affected.
For initial therapy, likely antimicrobial resistance should be assumed.[65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
If a cephalosporin cannot be administered (e.g., with an allergy), alternative antibiotics include a carbapenem (e.g., meropenem) or chloramphenicol. Trimethoprim/sulfamethoxazole is an alternative drug for ampicillin (excluding newborns).
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Primary options
ampicillin: neonates: consult specialist for guidance on dose; children: 100-200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
and
vancomycin: neonates: consult specialist for guidance on dose; children: 15 mg/kg intravenously every 6 hours; adults: 15-20 mg/kg intravenously every 8-12 hours
-- AND --
ceftriaxone: neonates: consult specialist for guidance on dose; children: 100 mg/kg/day intravenously given in divided doses every 12-24 hours; adults: 2 g intravenously every 12 hours
or
cefotaxime: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
sulfamethoxazole/trimethoprim: children >2 months of age: 15-20 mg/kg/day intravenously given in divided doses every 6-8 hours; adults: 8-10 mg/kg/day intravenously given in divided doses every 6-12 hours
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
and
vancomycin: neonates: consult specialist for guidance on dose; children: 15 mg/kg intravenously every 6 hours; adults: 15-20 mg/kg intravenously every 8-12 hours
-- AND --
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
or
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Streptococcus pneumoniae
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Penicillin-susceptible organisms (i.e., minimum inhibitory concentration <0.1 microgram/mL) should be treated with penicillin-G or ampicillin.
Patients with a penicillin allergy may use chloramphenicol. Treatment course: 10 to 14 days.
Primary options
penicillin G potassium: neonates: consult specialist for guidance on dose; children: 250,000 to 300,000 units/kg/day intravenously given in divided doses every 4-6 hours, maximum 24 million units/day; adults: 2 million units intravenously every 2 hours
OR
ampicillin: neonates: consult specialist for guidance on dose; children: 100-200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
dexamethasone
Treatment recommended for ALL patients in selected patient group
Ideally, adjuvant dexamethasone should be given with or shortly before the first dose of parenteral antibiotics in all previously well and non-immunosuppressed adults and children.[68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com However, it may be given within 4 hours of the first dose of antibiotics.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Evidence of potential benefit has been demonstrated in cases of bacterial meningitis associated with Haemophilus influenzae or Streptococcus pneumoniae. There is little evidence to support the use of dexamethasone in cases caused by other bacteria.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Adjunctive therapy with dexamethasone, given before or within 4 hours of the first dose of antibiotics and continued for 4 days, has been shown to improve outcomes in adults.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com [71]de Gans J, van der Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56. https://www.nejm.org/doi/10.1056/NEJMoa021334 http://www.ncbi.nlm.nih.gov/pubmed/12432041?tool=bestpractice.com [72]van de Beek D, de Gans J, McIntyre P, et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43. http://www.ncbi.nlm.nih.gov/pubmed/14998499?tool=bestpractice.com [73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com [74]Beez T, Steiger HJ, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis. BMC Neurol. 2017 Dec 7;17(1):209. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-017-0994-z http://www.ncbi.nlm.nih.gov/pubmed/29212462?tool=bestpractice.com
One Cochrane review found insufficient evidence to demonstrate that adding corticosteroids to antibacterial therapy reduced overall mortality in a mixed population of adults and children with acute bacterial meningitis.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
Significant reduction in rates of hearing loss and neurologic sequelae were, however, reported in adults and children; short-term neurologic sequelae were reduced in children, but not in adults.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
[ ]
In children with acute bacterial meningitis, is there randomized controlled trial evidence to support adding corticosteroids to standard treatment with antibacterial agents?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1217/fullShow me the answer
[
]
In adults with acute bacterial meningitis, is adding corticosteroids to standard treatment with antibacterial agents helpful?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1273/fullShow me the answer These results were replicated in a subsequent meta-analysis of randomized controlled trials related to the treatment of bacterial meningitis in children with dexamethasone.[75]Wang Y, Liu X, Wang Y, et al. Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children. Childs Nerv Syst. 2018 Feb;34(2):217-23.
http://www.ncbi.nlm.nih.gov/pubmed/29188363?tool=bestpractice.com
Subgroup analyses of the Cochrane review suggested that corticosteroids may reduce: mortality in S pneumoniae meningitis (but not in H influenzae type b [Hib] or Neisseria meningitidis meningitis); severe hearing loss in children with Hib meningitis (but not in children with meningitis due to non-Haemophilus species).[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
One meta-analysis that included a heterogeneous group of critically ill adult patients reported potentially improved survival among a subgroup of patients with bacterial meningitis who received corticosteroids compared with those who did not (mortality 28% vs. 32%; P=0.04).[76]Martino EA, Baiardo Redaelli M, Sardo S, et al. Steroids and survival in critically ill adult patients: a meta-analysis of 135 randomized trials. J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2252-60. http://www.ncbi.nlm.nih.gov/pubmed/29793761?tool=bestpractice.com
Corticosteroids are not currently recommended in neonates.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Primary options
dexamethasone sodium phosphate: children ≥1 month of age: 0.6 mg/kg/day intravenously given in divided doses every 6 hours; adults: 10 mg intravenously every 6 hours
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Penicillin-intermediate organisms (i.e., minimum inhibitory concentration 0.1 to 1.0 microgram/mL) should be treated with cefotaxime or ceftriaxone.
If a cephalosporin cannot be administered (e.g., with an allergy), alternative antibiotics are a carbapenem (e.g., meropenem) or chloramphenicol.
Treatment course: 10 to 14 days.
Primary options
ceftriaxone: neonates: consult specialist for guidance on dose; children: 100 mg/kg/day intravenously given in divided doses every 12-24 hours; adults: 2 g intravenously every 12 hours
OR
cefotaxime: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
OR
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
dexamethasone
Treatment recommended for ALL patients in selected patient group
Ideally, adjuvant dexamethasone should be given with or shortly before the first dose of parenteral antibiotics in all previously well and non-immunosuppressed adults and children.[68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com However, it may be given within 4 hours of the first dose of antibiotics.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Evidence of potential benefit has been demonstrated in cases of bacterial meningitis associated with Haemophilus influenzae or Streptococcus pneumoniae. There is little evidence to support the use of dexamethasone in cases caused by other bacteria.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Adjunctive therapy with dexamethasone, given before or within 4 hours of the first dose of antibiotics and continued for 4 days, has been shown to improve outcomes in adults.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com [71]de Gans J, van der Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56. https://www.nejm.org/doi/10.1056/NEJMoa021334 http://www.ncbi.nlm.nih.gov/pubmed/12432041?tool=bestpractice.com [72]van de Beek D, de Gans J, McIntyre P, et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43. http://www.ncbi.nlm.nih.gov/pubmed/14998499?tool=bestpractice.com [73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com [74]Beez T, Steiger HJ, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis. BMC Neurol. 2017 Dec 7;17(1):209. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-017-0994-z http://www.ncbi.nlm.nih.gov/pubmed/29212462?tool=bestpractice.com
One Cochrane review found insufficient evidence to demonstrate that adding corticosteroids to antibacterial therapy reduced overall mortality in a mixed population of adults and children with acute bacterial meningitis.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
Significant reduction in rates of hearing loss and neurologic sequelae were, however, reported in adults and children; short-term neurologic sequelae were reduced in children, but not in adults.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
[ ]
In children with acute bacterial meningitis, is there randomized controlled trial evidence to support adding corticosteroids to standard treatment with antibacterial agents?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1217/fullShow me the answer
[
]
In adults with acute bacterial meningitis, is adding corticosteroids to standard treatment with antibacterial agents helpful?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1273/fullShow me the answer These results were replicated in a subsequent meta-analysis of randomized controlled trials related to the treatment of bacterial meningitis in children with dexamethasone.[75]Wang Y, Liu X, Wang Y, et al. Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children. Childs Nerv Syst. 2018 Feb;34(2):217-23.
http://www.ncbi.nlm.nih.gov/pubmed/29188363?tool=bestpractice.com
Subgroup analyses of the Cochrane review suggested that corticosteroids may reduce: mortality in S pneumoniae meningitis (but not in H influenzae type b [Hib] or Neisseria meningitidis meningitis); severe hearing loss in children with Hib meningitis (but not in children with meningitis due to non-Haemophilus species).[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
One meta-analysis that included a heterogeneous group of critically ill adult patients reported potentially improved survival among a subgroup of patients with bacterial meningitis who received corticosteroids compared with those who did not (mortality 28% vs. 32%; P=0.04).[76]Martino EA, Baiardo Redaelli M, Sardo S, et al. Steroids and survival in critically ill adult patients: a meta-analysis of 135 randomized trials. J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2252-60. http://www.ncbi.nlm.nih.gov/pubmed/29793761?tool=bestpractice.com
Corticosteroids are not currently recommended in neonates.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Primary options
dexamethasone sodium phosphate: children ≥1 month of age: 0.6 mg/kg/day intravenously given in divided doses every 6 hours; adults: 10 mg intravenously every 6 hours
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Penicillin-resistant (minimum inhibitory concentration [MIC] ≥2.0 micrograms/mL) or cephalosporin-resistant organisms (MIC ≥1.0 microgram/mL) should be treated with vancomycin in addition to cefotaxime or ceftriaxone.
If a cephalosporin cannot be administered (e.g., with an allergy), alternative antibiotics are a carbapenem (e.g., meropenem) or chloramphenicol.
Treatment course: 10 to 14 days.
Primary options
vancomycin: neonates: consult specialist for guidance on dose; children: 15 mg/kg intravenously every 6 hours; adults: 15-20 mg/kg intravenously every 8-12 hours
-- AND --
ceftriaxone: neonates: consult specialist for guidance on dose; children: 100 mg/kg/day intravenously given in divided doses every 12-24 hours; adults: 2 g intravenously every 12 hours
or
cefotaxime: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
vancomycin: neonates: consult specialist for guidance on dose; children: 15 mg/kg intravenously every 6 hours; adults: 15-20 mg/kg intravenously every 8-12 hours
-- AND --
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
or
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
dexamethasone
Treatment recommended for ALL patients in selected patient group
Ideally, adjuvant dexamethasone should be given with or shortly before the first dose of parenteral antibiotics in all previously well and non-immunosuppressed adults and children.[68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com However, it may be given within 4 hours of the first dose of antibiotics.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Evidence of potential benefit has been demonstrated in cases of bacterial meningitis associated with Haemophilus influenzae or Streptococcus pneumoniae. There is little evidence to support the use of dexamethasone in cases caused by other bacteria.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Adjunctive therapy with dexamethasone, given before or within 4 hours of the first dose of antibiotics and continued for 4 days, has been shown to improve outcomes in adults.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com [71]de Gans J, van der Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56. https://www.nejm.org/doi/10.1056/NEJMoa021334 http://www.ncbi.nlm.nih.gov/pubmed/12432041?tool=bestpractice.com [72]van de Beek D, de Gans J, McIntyre P, et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43. http://www.ncbi.nlm.nih.gov/pubmed/14998499?tool=bestpractice.com [73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com [74]Beez T, Steiger HJ, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis. BMC Neurol. 2017 Dec 7;17(1):209. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-017-0994-z http://www.ncbi.nlm.nih.gov/pubmed/29212462?tool=bestpractice.com
One Cochrane review found insufficient evidence to demonstrate that adding corticosteroids to antibacterial therapy reduced overall mortality in a mixed population of adults and children with acute bacterial meningitis.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
Significant reduction in rates of hearing loss and neurologic sequelae were, however, reported in adults and children; short-term neurologic sequelae were reduced in children, but not in adults.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
[ ]
In children with acute bacterial meningitis, is there randomized controlled trial evidence to support adding corticosteroids to standard treatment with antibacterial agents?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1217/fullShow me the answer
[
]
In adults with acute bacterial meningitis, is adding corticosteroids to standard treatment with antibacterial agents helpful?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1273/fullShow me the answer These results were replicated in a subsequent meta-analysis of randomized controlled trials related to the treatment of bacterial meningitis in children with dexamethasone.[75]Wang Y, Liu X, Wang Y, et al. Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children. Childs Nerv Syst. 2018 Feb;34(2):217-23.
http://www.ncbi.nlm.nih.gov/pubmed/29188363?tool=bestpractice.com
Subgroup analyses of the Cochrane review suggested that corticosteroids may reduce: mortality in S pneumoniae meningitis (but not in H influenzae type b [Hib] or Neisseria meningitidis meningitis); severe hearing loss in children with Hib meningitis (but not in children with meningitis due to non-Haemophilus species).[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
One meta-analysis that included a heterogeneous group of critically ill adult patients reported potentially improved survival among a subgroup of patients with bacterial meningitis who received corticosteroids compared with those who did not (mortality 28% vs. 32%; P=0.04).[76]Martino EA, Baiardo Redaelli M, Sardo S, et al. Steroids and survival in critically ill adult patients: a meta-analysis of 135 randomized trials. J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2252-60. http://www.ncbi.nlm.nih.gov/pubmed/29793761?tool=bestpractice.com
Corticosteroids are not currently recommended in neonates.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Primary options
dexamethasone sodium phosphate: children ≥1 month of age: 0.6 mg/kg/day intravenously given in divided doses every 6 hours; adults: 10 mg intravenously every 6 hours
confirmed infection: Haemophilus influenzae
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: 7 to 10 days.
Primary options
ampicillin: neonates: consult specialist for guidance on dose; children: 100-200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
OR
sulfamethoxazole/trimethoprim: children >2 months of age: 15-20 mg/kg/day intravenously given in divided doses every 6-8 hours; adults: 8-10 mg/kg/day intravenously given in divided doses every 6-12 hours
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
dexamethasone
Treatment recommended for ALL patients in selected patient group
Ideally, adjuvant dexamethasone should be given with or shortly before the first dose of parenteral antibiotics in all previously well and non-immunosuppressed adults and children.[68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com However, it may be given within 4 hours of the first dose of antibiotics.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Evidence of potential benefit has been demonstrated in cases of bacterial meningitis associated with Haemophilus influenzae or Streptococcus pneumoniae. There is little evidence to support the use of dexamethasone in cases caused by other bacteria.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Adjunctive therapy with dexamethasone, given before or within 4 hours of the first dose of antibiotics and continued for 4 days, has been shown to improve outcomes in adults.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com [71]de Gans J, van der Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56. https://www.nejm.org/doi/10.1056/NEJMoa021334 http://www.ncbi.nlm.nih.gov/pubmed/12432041?tool=bestpractice.com [72]van de Beek D, de Gans J, McIntyre P, et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43. http://www.ncbi.nlm.nih.gov/pubmed/14998499?tool=bestpractice.com [73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com [74]Beez T, Steiger HJ, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis. BMC Neurol. 2017 Dec 7;17(1):209. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-017-0994-z http://www.ncbi.nlm.nih.gov/pubmed/29212462?tool=bestpractice.com
One Cochrane review found insufficient evidence to demonstrate that adding corticosteroids to antibacterial therapy reduced overall mortality in a mixed population of adults and children with acute bacterial meningitis.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
Significant reduction in rates of hearing loss and neurologic sequelae were, however, reported in adults and children; short-term neurologic sequelae were reduced in children, but not in adults.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
[ ]
In children with acute bacterial meningitis, is there randomized controlled trial evidence to support adding corticosteroids to standard treatment with antibacterial agents?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1217/fullShow me the answer
[
]
In adults with acute bacterial meningitis, is adding corticosteroids to standard treatment with antibacterial agents helpful?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1273/fullShow me the answer These results were replicated in a subsequent meta-analysis of randomized controlled trials related to the treatment of bacterial meningitis in children with dexamethasone.[75]Wang Y, Liu X, Wang Y, et al. Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children. Childs Nerv Syst. 2018 Feb;34(2):217-23.
http://www.ncbi.nlm.nih.gov/pubmed/29188363?tool=bestpractice.com
Subgroup analyses of the Cochrane review suggested that corticosteroids may reduce: mortality in S pneumoniae meningitis (but not in H influenzae type b [Hib] or Neisseria meningitidis meningitis); severe hearing loss in children with Hib meningitis (but not in children with meningitis due to non-Haemophilus species).[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
One meta-analysis that included a heterogeneous group of critically ill adult patients reported potentially improved survival among a subgroup of patients with bacterial meningitis who received corticosteroids compared with those who did not (mortality 28% vs. 32%; P=0.04).[76]Martino EA, Baiardo Redaelli M, Sardo S, et al. Steroids and survival in critically ill adult patients: a meta-analysis of 135 randomized trials. J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2252-60. http://www.ncbi.nlm.nih.gov/pubmed/29793761?tool=bestpractice.com
Corticosteroids are not currently recommended in neonates.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Primary options
dexamethasone sodium phosphate: children ≥1 month of age: 0.6 mg/kg/day intravenously given in divided doses every 6 hours; adults: 10 mg intravenously every 6 hours
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
If a cephalosporin cannot be administered (e.g., with an allergy), alternative antibiotics are a carbapenem (e.g., meropenem) or chloramphenicol.
Treatment course: 10 to 14 days.
Primary options
ceftriaxone: neonates: consult specialist for guidance on dose; children: 100 mg/kg/day intravenously given in divided doses every 12-24 hours; adults: 2 g intravenously every 12 hours
OR
cefotaxime: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
OR
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
dexamethasone
Treatment recommended for ALL patients in selected patient group
Ideally, adjuvant dexamethasone should be given with or shortly before the first dose of parenteral antibiotics in all previously well and non-immunosuppressed adults and children.[68]Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2008.02193.x http://www.ncbi.nlm.nih.gov/pubmed/18582342?tool=bestpractice.com However, it may be given within 4 hours of the first dose of antibiotics.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Evidence of potential benefit has been demonstrated in cases of bacterial meningitis associated with Haemophilus influenzae or Streptococcus pneumoniae. There is little evidence to support the use of dexamethasone in cases caused by other bacteria.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Adjunctive therapy with dexamethasone, given before or within 4 hours of the first dose of antibiotics and continued for 4 days, has been shown to improve outcomes in adults.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com [71]de Gans J, van der Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56. https://www.nejm.org/doi/10.1056/NEJMoa021334 http://www.ncbi.nlm.nih.gov/pubmed/12432041?tool=bestpractice.com [72]van de Beek D, de Gans J, McIntyre P, et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43. http://www.ncbi.nlm.nih.gov/pubmed/14998499?tool=bestpractice.com [73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com [74]Beez T, Steiger HJ, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis. BMC Neurol. 2017 Dec 7;17(1):209. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-017-0994-z http://www.ncbi.nlm.nih.gov/pubmed/29212462?tool=bestpractice.com
One Cochrane review found insufficient evidence to demonstrate that adding corticosteroids to antibacterial therapy reduced overall mortality in a mixed population of adults and children with acute bacterial meningitis.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
Significant reduction in rates of hearing loss and neurologic sequelae were, however, reported in adults and children; short-term neurologic sequelae were reduced in children, but not in adults.[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
[ ]
In children with acute bacterial meningitis, is there randomized controlled trial evidence to support adding corticosteroids to standard treatment with antibacterial agents?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1217/fullShow me the answer
[
]
In adults with acute bacterial meningitis, is adding corticosteroids to standard treatment with antibacterial agents helpful?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1273/fullShow me the answer These results were replicated in a subsequent meta-analysis of randomized controlled trials related to the treatment of bacterial meningitis in children with dexamethasone.[75]Wang Y, Liu X, Wang Y, et al. Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children. Childs Nerv Syst. 2018 Feb;34(2):217-23.
http://www.ncbi.nlm.nih.gov/pubmed/29188363?tool=bestpractice.com
Subgroup analyses of the Cochrane review suggested that corticosteroids may reduce: mortality in S pneumoniae meningitis (but not in H influenzae type b [Hib] or Neisseria meningitidis meningitis); severe hearing loss in children with Hib meningitis (but not in children with meningitis due to non-Haemophilus species).[73]Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full http://www.ncbi.nlm.nih.gov/pubmed/26362566?tool=bestpractice.com
One meta-analysis that included a heterogeneous group of critically ill adult patients reported potentially improved survival among a subgroup of patients with bacterial meningitis who received corticosteroids compared with those who did not (mortality 28% vs. 32%; P=0.04).[76]Martino EA, Baiardo Redaelli M, Sardo S, et al. Steroids and survival in critically ill adult patients: a meta-analysis of 135 randomized trials. J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2252-60. http://www.ncbi.nlm.nih.gov/pubmed/29793761?tool=bestpractice.com
Corticosteroids are not currently recommended in neonates.[38]van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00020-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27062097?tool=bestpractice.com
Primary options
dexamethasone sodium phosphate: children ≥1 month of age: 0.6 mg/kg/day intravenously given in divided doses every 6 hours; adults: 10 mg intravenously every 6 hours
confirmed infection: Streptococcus agalactiae (group B streptococci)
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
An alternative antibiotic for patients with a penicillin allergy is chloramphenicol.
Treatment course: 14 to 21 days.
Primary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
-- AND --
penicillin G potassium: neonates: consult specialist for guidance on dose; children: 250,000 to 300,000 units/kg/day intravenously given in divided doses every 4-6 hours, maximum 24 million units/day; adults: 2 million units intravenously every 2 hours
or
ampicillin: neonates: consult specialist for guidance on dose; children: 100-200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
and
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Escherichia coli and other gram-negative Enterobacteriaceae
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
If a cephalosporin cannot be administered (e.g., with an allergy), alternative antibiotics are a carbapenem (e.g., meropenem) or chloramphenicol.
Treatment course: 21 to 28 days.
Primary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
-- AND --
ceftriaxone: neonates: consult specialist for guidance on dose; children: 100 mg/kg/day intravenously given in divided doses every 12-24 hours; adults: 2 g intravenously every 12 hours
or
cefotaxime: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
-- AND --
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
or
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Listeria monocytogenes
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and antibiotic susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
An alternative antibiotic for patients with a penicillin allergy is chloramphenicol.
Treatment course: 21 to 28 days.
Primary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
-- AND --
penicillin G potassium: neonates: consult specialist for guidance on dose; children: 250,000 to 300,000 units/kg/day intravenously given in divided doses every 4-6 hours, maximum 24 million units/day; adults: 2 million units intravenously every 2 hours
or
ampicillin: neonates: consult specialist for guidance on dose; children: 100-200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
and
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Staphylococcus aureus
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: depends on microbiologic response of cerebrospinal fluid and underlying illness.
Primary options
nafcillin: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 4 hours; adults: 2 g intravenously every 4 hours
OR
oxacillin: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 4 hours; adults: 2 g intravenously every 4 hours
Secondary options
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: depends on microbiologic response of cerebrospinal fluid and underlying illness.
Primary options
vancomycin: neonates: consult specialist for guidance on dose; children: 15 mg/kg intravenously every 6 hours; adults: 15-20 mg/kg intravenously every 8-12 hours
Secondary options
sulfamethoxazole/trimethoprim: children >2 months of age: 15-20 mg/kg/day intravenously given in divided doses every 6-8 hours; adults: 8-10 mg/kg/day intravenously given in divided doses every 6-12 hours
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
OR
linezolid: neonates: consult specialist for guidance on dose; children: 20-30 mg/kg/day intravenously given in divided doses every 8-12 hours; adults: 600 mg intravenously every 12 hours
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Staphylococcus epidermidis
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and antibiotic susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: depends on microbiologic response of cerebrospinal fluid and underlying illness.
Primary options
vancomycin: neonates: consult specialist for guidance on dose; children: 15 mg/kg intravenously every 6 hours; adults: 15-20 mg/kg intravenously every 8-12 hours
Secondary options
linezolid: neonates: consult specialist for guidance on dose; children: 20-30 mg/kg/day intravenously given in divided doses every 8-12 hours; adults: 600 mg intravenously every 12 hours
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Pseudomonas aeruginosa
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and its susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: 21 days.
Primary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
and
ceftazidime sodium: neonates: consult specialist for guidance on dose; children: 150 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
Secondary options
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Enterococcus species
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and antibiotic susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: 21 days.
Primary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
and
ampicillin: neonates: consult specialist for guidance on dose; children: 100-200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
and
sulfamethoxazole/trimethoprim: children >2 months of age: 15-20 mg/kg/day intravenously given in divided doses every 6-8 hours; adults: 8-10 mg/kg/day intravenously given in divided doses every 6-12 hours
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Acinetobacter species
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and antibiotic susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: 21 days.
Primary options
gentamicin: neonates: consult specialist for guidance on dose; children: 2 mg/kg intravenously every 8 hours; adults: 1 mg/kg intravenously every 8 hours
and
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1 g intravenously every 8 hours
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
confirmed infection: Neisseria meningitidis
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and antibiotic susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: 7 days.
Primary options
penicillin G potassium: neonates: consult specialist for guidance on dose; children: 250,000 to 300,000 units/kg/day intravenously given in divided doses every 4-6 hours, maximum 24 million units/day; adults: 2 million units intravenously every 2 hours
OR
ampicillin: neonates: consult specialist for guidance on dose; children: 100-200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
ceftriaxone: neonates: consult specialist for guidance on dose; children: 100 mg/kg/day intravenously given in divided doses every 12-24 hours; adults: 2 g intravenously every 12 hours
OR
cefotaxime: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
OR
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
targeted antibiotic therapy
After diagnosis is confirmed (generally within 12-48 hours of admission to the hospital), antimicrobial therapy can be modified according to the causative organism and antibiotic susceptibilities.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com [65]Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017 Mar;64(6):701-6. https://academic.oup.com/cid/article/64/6/701/3060377 http://www.ncbi.nlm.nih.gov/pubmed/28203777?tool=bestpractice.com
Treatment course: 7 days.
Primary options
ceftriaxone: neonates: consult specialist for guidance on dose; children: 100 mg/kg/day intravenously given in divided doses every 12-24 hours; adults: 2 g intravenously every 12 hours
OR
cefotaxime: neonates: consult specialist for guidance on dose; children: 200 mg/kg/day intravenously given in divided doses every 6 hours; adults: 2 g intravenously every 4 hours
Secondary options
meropenem: neonates: consult specialist for guidance on dose; children: 120 mg/kg/day intravenously given in divided doses every 8 hours; adults: 1-2 g intravenously every 8 hours
OR
chloramphenicol: neonates: consult specialist for guidance on dose; children and adults: 50-100 mg/kg/day intravenously given in divided doses every 6 hours, maximum 4000 mg/day
supportive therapy
Treatment recommended for ALL patients in selected patient group
Patients with symptoms of compensated shock (neurologic status usually remains normal, but the pulse rate may be persistently elevated, the skin mottled, the extremities cool due to increased systemic vascular resistance, the capillary refilling prolonged, and the urinary output decreased) or respiratory distress should receive supplemental oxygen. Those with decompensated shock (signs of compensated shock plus hypotension), hypoxia, severe respiratory distress, altered consciousness, or evidence of elevated intracranial pressure require intubation and mechanical ventilation.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
Adequate oxygenation, prevention of hypoglycemia and hyponatremia, anticonvulsant therapy to control and prevent seizures (e.g., lorazepam, diazepam, phenytoin), and measures to decrease intracranial pressure and to prevent fluctuating cerebral blood flow are important in management.[9]Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. http://www.ncbi.nlm.nih.gov/pubmed/12826449?tool=bestpractice.com
Vasopressors (e.g., epinephrine, norepinephrine, milrinone, dopamine) should be given to patients with hypotension or poor perfusion who do not respond promptly to fluid resuscitation.
If the patient is hypovolemic or in shock, additional intravenous fluids must be given.
Fluids should be given cautiously to patients with evidence of elevated intracranial pressure, myocardial dysfunction, or acute respiratory distress syndrome.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer